Successful use of a topical mixture with ozolipoile in the treatment of actinic ulcers

Figures & data

Figure 1 VAS (Visual Analog Scale) for the monitoring of pain.

Table 1 Baseline data related to the ulcerate in T₁ and T₂ groups

Baseline data	T1 group	T2 group
	Mean	Mean
Area of the ulcer (cm)	3.8	4.1
Duration in days	5	7

Notes: T₁, test group treated with a mixture called ozolipoile; T₂, control group treated with a combined administration of hyaluronic acid gel followed by a non-ablative laser/radiofrequency/intense pulsed light therapy.

Table 2 Synoptical table comparing the T1 and T2 VAS scores

	VAS scores
	Baseline	Day 1	Day 3	Day 5	Day 7	D1–D7 variation
Group T1
Median	9.0±0.5	7±1.5	5±0.5	2.5±0.5	1±1	92.7%
Mean		8.3	5.3	2.5	0.5	7.7
Group T2
Median	9.5±0.5	7±1	6.5±1.5	3.5±1.5	2±1	67.5%
Mean		7.7	6.5	3.5	2.5	5.2

Notes: T₁, test group treated with a mixture called ozolipoile; T₂, control group treated with a combined administration of hyaluronic acid gel followed by a non-ablative laser/RF/IPL therapy.

Abbreviations: VAS, Visual Analog Scale; RF, radiofrequency; IPL, intense pulsed light.

Figure 2 Actinic lesion with a wide erythematous area: a case–control study. The same case–control study 7 days after beginning of T₁ treatment.